| Utility: Compounds for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 | 5 Jun 2018 | 9 Aug 2022 |
| Utility: Methods for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 26 Jul 2022 | 27 Jun 2018 | 26 Jul 2022 |
| Utility: 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof Filling date: 8 Sep 2025 Issue date: 19 Jul 2022 | 10 Aug 2020 | 19 Jul 2022 |
| Utility: Methods for treating Huntington's Disease Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 | 27 Jun 2018 | 12 Jul 2022 |
| Utility: Process for the production of alpha-tocotrienol and derivatives Filling date: 8 Sep 2025 Issue date: 26 Apr 2022 | 10 Sep 2018 | 26 Apr 2022 |
| Utility: Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Filling date: 8 Sep 2025 Issue date: 19 Apr 2022 | 1 Jul 2020 | 19 Apr 2022 |
| Utility: Methods for enriching alpha-tocotrienol from mixed tocol compositions Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 | 17 Aug 2020 | 30 Nov 2021 |
| Utility: Substituted reverse pyrimidine Bmi-1 inhibitors Filling date: 8 Sep 2025 Issue date: 23 Nov 2021 | 26 Sep 2019 | 23 Nov 2021 |
| Utility: 2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 | 30 Mar 2021 | 16 Nov 2021 |
| Utility: Methods of administering deflazacort therapy Filling date: 8 Sep 2025 Issue date: 10 Aug 2021 | 26 May 2017 | 10 Aug 2021 |
| Utility: Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 | 6 Jul 2020 | 20 Apr 2021 |
| Utility: 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 | 20 Dec 2018 | 6 Apr 2021 |
| Utility: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease Filling date: 8 Sep 2025 Issue date: 30 Mar 2021 | 10 Apr 2019 | 30 Mar 2021 |
| Utility: Processes for the preparation of substituted tetrahydro beta-carbolines Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 24 Sep 2019 | 16 Mar 2021 |
| Utility: Methods for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 | 11 Dec 2019 | 5 Jan 2021 |
| Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 | 13 Apr 2018 | 5 Jan 2021 |
| Utility: Methods for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 11 Dec 2016 | 29 Dec 2020 |
| Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 | 15 Aug 2019 | 1 Dec 2020 |
| Utility: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 | 4 Dec 2018 | 1 Dec 2020 |
| Utility: Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 | 14 Mar 2019 | 25 Aug 2020 |
| Utility: Methods for enriching alpha-tocotrienol from mixed tocol compositions Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 | 16 Dec 2016 | 18 Aug 2020 |
| Utility: Treatment of pervasive developmental disorders with redox-active therapeutics Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 | 19 Oct 2018 | 11 Aug 2020 |
| Utility: 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 | 15 Nov 2017 | 11 Aug 2020 |
| Utility: Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders Filling date: 8 Sep 2025 Issue date: 7 Jul 2020 | 17 Dec 2016 | 7 Jul 2020 |
| Utility: Methods for modulating the amount of RNA transcripts Filling date: 8 Sep 2025 Issue date: 23 Jun 2020 | 15 Jan 2019 | 23 Jun 2020 |
| Utility: Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease Filling date: 8 Sep 2025 Issue date: 9 Jun 2020 | 29 Mar 2019 | 9 Jun 2020 |
| Utility: Methods for modulating RNA splicing Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 | 27 May 2016 | 2 Jun 2020 |
| Utility: Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 | 18 Jan 2019 | 14 Apr 2020 |
| Utility: Substituted pyridine and pyrazine BMI-1 inhibitors Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 | 21 Nov 2013 | 10 Mar 2020 |
| Utility: Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease Filling date: 8 Sep 2025 Issue date: 11 Feb 2020 | 3 Jun 2016 | 11 Feb 2020 |
| Utility: Methods for treating epilepsy Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 | 28 Oct 2016 | 31 Dec 2019 |
| Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 10 Dec 2019 | 9 Apr 2018 | 10 Dec 2019 |
| Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 | 5 Sep 2017 | 5 Nov 2019 |
| Utility: Substituted reverse pyrimidine Bmi-1 inhibitors Filling date: 8 Sep 2025 Issue date: 1 Oct 2019 | 21 Nov 2013 | 1 Oct 2019 |
| Utility: Substituted pyrimidine Bmi-1 inhibitors Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 | 21 Nov 2013 | 6 Aug 2019 |
